CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Income Statement [Abstract]
Revenue	$ 0	$ 0	$ 0	$ 0
Operating expenses:
Research and development	293,812	287,316	395,404	391,327
General and administrative	1,676,611	5,886,547	3,486,106	8,628,920
Waiver of common stock issuable	(1,542,000)		(1,542,000)
Total operating expenses	428,423	6,173,863	2,339,510	9,020,247
Loss from operations	(428,423)	(6,173,863)	(2,339,510)	(9,020,247)
Other income:
Interest income	36,340		46,382
Total	36,340		46,382
Net loss	$ (392,083)	$ (6,173,863)	$ (2,293,128)	$ (9,020,247)
Basic and diluted loss per common share (in dollars per share)	$ (0.04)	$ (0.71)	$ (0.23)	$ (1.04)
Weighted average common shares outstanding, basic and diluted (in shares)	10,150,810	8,719,441	9,771,833	8,633,253
COMPREHENSIVE LOSS
Net loss	$ (392,083)	$ (6,173,863)	$ (2,293,128)	$ (9,020,247)
Other comprehensive loss - loss on foreign currency translation	(25,014)	(30,040)	(25,736)	(15,610)
Total comprehensive loss	$ (417,097)	$ (6,203,903)	$ (2,318,864)	$ (9,035,857)